Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells Under Hypoxic and Low-Glucose Conditions

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Zhu M, Yin F, Yang L, et al. Contribution of TIP30 to chemoresistance in laryngeal carcinoma. Cell Death Dis. 2014;5:e1468. doi:10.1038/cddis.2014.424
   PubMed Web of Science ®Google Scholar
• Fu Q, Liu P, Sun X, et al. Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway. Cancer Cell Int. 2017;17:79. doi:10.1186/s12935-017-0448-0
   PubMed Web of Science ®Google Scholar
• Wang C, Shao L, Pan C, et al. Elevated level of mitochondrial reactive oxygen species via fatty acid beta-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition. Stem Cell Res Ther. 2019;10:175. doi:10.1186/s13287-019-1265-2
   PubMed Web of Science ®Google Scholar
• Garcia-Mayea Y, Mir C, Munoz L, et al. Autophagy inhibition as a promising therapeutic target for laryngeal cancer. Carcinogenesis. 2019;40:1525–1534. doi:10.1093/carcin/bgz080
   PubMed Web of Science ®Google Scholar
• Zhong JT, Yu Q, Zhou SH, et al. GLUT-1 siRNA enhances radiosensitization of laryngeal cancer stem cells via enhanced DNA damage, cell cycle redistribution, and promotion of apoptosis in vitro and in vivo. Onco Targets Ther. 2019;12:9129–9142. doi:10.2147/OTT.S221423
   PubMed Web of Science ®Google Scholar
• Chen XH, Bao YY, Zhou SH, et al. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells. Mol Med Rep. 2013;8:1695–1700. doi:10.3892/mmr.2013.1740
   PubMed Web of Science ®Google Scholar
• Jang JW, Song Y, Kim SH, et al. CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma. Cancer Lett. 2017;389:1–10. doi:10.1016/j.canlet.2016.12.023
   PubMed Web of Science ®Google Scholar
• Garg N, Bakhshinyan D, Venugopal C, et al. CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence. Oncogene. 2017;36:606–617. doi:10.1038/onc.2016.235
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou L, Dou T, et al. BMI1’S maintenance of the proliferative capacity of laryngeal cancer stem cells. Head Neck. 2011;33:1115–1125. doi:10.1002/hed.21576
   PubMed Web of Science ®Google Scholar
• Xu Z, Han X, Ou D, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104:575–587. doi:10.1007/s00253-019-10257-8
   PubMed Web of Science ®Google Scholar
• Yang H, Ni HM, Ding WX. The double-edged sword of MTOR in autophagy deficiency induced-liver injury and tumorigenesis. Autophagy. 2019;15:1671–1673. doi:10.1080/15548627.2019.1634445
   PubMed Web of Science ®Google Scholar
• Pereira DL, Dos Santos Ferreira AC, de Faria GP, Kwee JK. Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer. Pathol Oncol Res. 2015;21:103–111. doi:10.1007/s12253-014-9794-6
   PubMed Web of Science ®Google Scholar
• Song YJ, Zhang SS, Guo XL, et al. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett. 2013;339:70–81. doi:10.1016/j.canlet.2013.07.021
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang D, Zhang L, et al. Upregulation of autophagy by hypoxia-inducible factor-1alpha promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia. Oncol Rep. 2014;32:935–942. doi:10.3892/or.2014.3298
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang D, Liu Y, et al. Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells. Cancer Cell Int. 2013;13:119. doi:10.1186/1475-2867-13-119
   PubMed Web of Science ®Google Scholar
• Yuen CA, Asuthkar S, Guda MR, Tsung AJ, Velpula KK. Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept. CNS Oncol. 2016;5:101–108. doi:10.2217/cns-2015-0006
   PubMedGoogle Scholar
• Nazio F, Bordi M, Cianfanelli V, Locatelli F, Cecconi F. Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications. Cell Death Differ. 2019;26:690–702. doi:10.1038/s41418-019-0292-y
   PubMed Web of Science ®Google Scholar
• Rothe K, Porter V, Jiang X. Current Outlook on Autophagy in Human Leukemia: foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions. Int J Mol Sci. 2019;20(3):461. doi:10.3390/ijms20030461
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao H, Wang D, et al. Inhibition of Autophagy Promoted Apoptosis and Suppressed Growth of Hepatocellular Carcinoma Upon Photothermal Exposure. J Biomed Nanotechnol. 2019;15:813–821. doi:10.1166/jbn.2019.2714
   PubMed Web of Science ®Google Scholar
• Roy S, Leidal AM, Ye J, Ronen SM, Autophagy-Dependent DJ. Shuttling of TBC1D5 Controls Plasma Membrane Translocation of GLUT1 and Glucose Uptake. Mol Cell. 2017;67:84–95 e5. doi:10.1016/j.molcel.2017.05.020
   PubMed Web of Science ®Google Scholar
• Zhu L, Wu G, Yang X, et al. Low density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells. Sci Rep. 2019;9:3020. doi:10.1038/s41598-019-39559-7
   PubMed Web of Science ®Google Scholar
• Roy S, Debnath J. Autophagy enables retromer-dependent plasma membrane translocation of SLC2A1/GLUT1 to enhance glucose uptake. Autophagy. 2017;13:2013–2014. doi:10.1080/15548627.2017.1371397
   PubMed Web of Science ®Google Scholar
• Wan B, Zang Y, Wang L. Overexpression of Beclin1 inhibits proliferation and promotes apoptosis of human laryngeal squamous carcinoma cell Hep-2. Onco Targets Ther. 2018;11:3827–3833. doi:10.2147/OTT.S148869
   PubMed Web of Science ®Google Scholar
• Karpathiou G, Sivridis E, Koukourakis M, et al. Autophagy and Bcl-2/BNIP3 death regulatory pathway in non-small cell lung carcinomas. APMIS. 2013;121:592–604. doi:10.1111/apm.12026
   PubMed Web of Science ®Google Scholar
• Kim S, Kim DH, Jung WH, Koo JS. Metabolic phenotypes in triple-negative breast cancer. Tumour Biol. 2013;34:1699–1712. doi:10.1007/s13277-013-0707-1
   PubMedGoogle Scholar
• Choi J, Kim DH, Jung WH, Koo JS. Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype. Breast Cancer Res. 2013;15:R78. doi:10.1186/bcr3472
   PubMed Web of Science ®Google Scholar
• Lin W, Yin CY, Yu Q, et al. Expression of glucose transporter-1, hypoxia inducible factor-1alpha and beclin-1 in head and neck cancer and their implication. Int J Clin Exp Pathol. 2018;11:3708–3717.
   PubMed Web of Science ®Google Scholar
• Hubbi ME, Hu H, Kshitiz, et al. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J Biol Chem. 2013;288:10703–10714. doi:10.1074/jbc.M112.414771
   PubMed Web of Science ®Google Scholar
• Coppock JD, Lee JH. mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer. World J Otorhinolaryngol Head Neck Surg. 2016;2:76–83. doi:10.1016/j.wjorl.2016.05.010
   PubMedGoogle Scholar
• Xi J, Wang Y, Liu HGLUT-1. participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells. Gene. 2020;726:144194. doi:10.1016/j.gene.2019.144194
   PubMed Web of Science ®Google Scholar
• Lu ZJ, Yu Q, Zhou SH, et al. Construction of a GLUT-1 and HIF-1alpha gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique. Cancer Manag Res. 2019;11:2087–2096. doi:10.2147/CMAR.S183859
   PubMed Web of Science ®Google Scholar
• Luo XM, Xu B, Zhou ML, et al. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo. PLoS One. 2015;10:e0143306. doi:10.1371/journal.pone.0143306
   PubMed Web of Science ®Google Scholar
• Yan SX, Luo XM, Zhou SH, et al. Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma. Int J Med Sci. 2013;10:1375–1386. doi:10.7150/ijms.6855
   PubMed Web of Science ®Google Scholar
• Luo XM, Zhou SH, Fan J. Glucose transporter-1 as a new therapeutic target in laryngeal carcinoma. J Int Med Res. 2010;38(6):1885–1892. doi:10.1177/147323001003800601
   PubMed Web of Science ®Google Scholar
• Zhou SH, Fan J, Chen XM, Cheng KJ, Wang SQ. Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. Head Neck. 2009;31:1624–1633. doi:10.1002/hed.21137
   PubMed Web of Science ®Google Scholar
• Li LF, Zhou SH, Zhao K, et al. Clinical significance of FDG single-photon emission computed tomography: computed tomography in the diagnosis of head and neck cancers and study of its mechanism. Cancer Biother Radiopharm. 2008;23:701–714. doi:10.1089/cbr.2008.0510
   PubMed Web of Science ®Google Scholar
• Meng Y, Xu X, Luan H, et al. The progress and development of GLUT1 inhibitors targeting cancer energy metabolism. Future Med Chem. 2019;11:2333–2352. doi:10.4155/fmc-2019-0052
   PubMed Web of Science ®Google Scholar
• Endo H, Owada S, Inagaki Y, Shida Y, Tatemichi M. Glucose starvation induces LKB1-AMPK-mediated MMP-9 expression in cancer cells. Sci Rep. 2018;8:10122. doi:10.1038/s41598-018-28074-w
   PubMed Web of Science ®Google Scholar
• Lin Z, Weinberg JM, Malhotra R, et al. GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am J Physiol Endocrinol Metab. 2000;278:E958–66. doi:10.1152/ajpendo.2000.278.5.E958
   PubMed Web of Science ®Google Scholar
• Li K, Li M, Li W, et al. Airway epithelial regeneration requires autophagy and glucose metabolism. Cell Death Dis. 2019;10:875. doi:10.1038/s41419-019-2111-2
   PubMed Web of Science ®Google Scholar
• Yan L, RAJ P, Yao W, Ying H. Glucose metabolism in pancreatic cancer. Cancers (Basel). 2019;11(10):1460. doi:10.3390/cancers11101460
   PubMed Web of Science ®Google Scholar